JP Morgan analyst Andrea Teixeira maintained an Overweight rating and raised the price target from $88 to $93 on Jan. 16, 2026. This analyst has an accuracy rate of 60%. UBS analyst Peter Grom ...

Colgate-Palmolive (India) shares stayed under pressure after muted Q3FY26 results, as brokerages retained 'Sell' ratings citing weak volume growth, structural challenges in oral care, and limited ...

Jan 29 (Reuters) - Colgate-Palmolive (India) reported a marginal rise in third-quarter profit on Thursday, benefitting from ...

Colgate-Palmolive has just seen its price target updated, signaling that analysts are rethinking how they see the stock today ...

Colgate-Palmolive (India) posted a profit beat in Q3, with revenue growth remaining modest and margins easing year-on-year ...

The forecast represents essentially flat earnings compared with last year’s fourth quarter, while revenue is projected to edge up roughly 4% year-over-year. Colgate shares closed Wednesday at $85.00, ...

Colgate-Palmolive India reports Q3 net profit up 2.3% and sales up 1.4%, reflecting positive trends in core and premium ...

Recent commentary from Barclays and Wells Fargo has pushed Colgate-Palmolive (CL) into focus, as both banks highlight growing ...

If you have ever wondered whether Colgate-Palmolive at around US$85 per share is offering fair value or a stretched price, ...

With consumer staples stocks out of favor, Colgate-Palmolive's share price slumped in 2025. The company has accelerated its product development pace. Colgate-Palmolive has met or exceeded its organic ...

Colgate Palmolive India's net profit stayed flat in Q3FY26 at ₹323.9 crore as regulatory changes, including new labour codes and GST-related charges, weighed on earnings despite modest revenue growth ...

The toothpaste maker's net profit rose 0.3% to Rs 324 crore ($351.93 million) for the quarter ended December 31, from Rs 323 crore a year earlier. It had posted a 2% profit fall a year ago ...